BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7597327)

  • 1. [Sensitivity of ANCA in the surveillance of vasculitis].
    Godeau B; Perronne V; Gisselbrecht M; André C; Schaeffer A
    Rev Med Interne; 1995; 16(5):372-3. PubMed ID: 7597327
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative ANCA in Wegener's granulomatosis.
    Carrie S; Hughes KB; Watson MG
    J Laryngol Otol; 1994 May; 108(5):420-2. PubMed ID: 8035124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histopathological association of 29kD-ANCA and MPO-ANCA.
    Tervaert JW; Elema JD; Kallenberg CG
    APMIS Suppl; 1990; 19():35. PubMed ID: 2178358
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antineutrophil cytoplasmic antibodies: a new diagnostic tool].
    Papo T; Meyer O; Piette JC
    Rev Med Interne; 1991; 12(1):60-5. PubMed ID: 2041916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-ANCA as a marker of Wegener's disease.
    Franssen CF; Tervaert JW; Stegeman CA; Kallenberg CG
    Lancet; 1996 Jan; 347(8994):116; author reply 118. PubMed ID: 8538307
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible pathogenetic implications of ANCA in vasculitic syndromes.
    van der Woude FJ
    APMIS Suppl; 1990; 19():29-30. PubMed ID: 2285534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity and specificity of antineutrophil cytoplasmic antibodies in systemic vasculitis].
    Hachulla E; Hatron PY; Brouillard M; Cesbron JY; Reumaux D; Devulder B
    Rev Med Interne; 1994 May; 15(6):381-6. PubMed ID: 7914710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis.
    Tomer Y; Gilburd B; Blank M; Lider O; Hershkoviz R; Fishman P; Zigelman R; Meroni PL; Wiik A; Shoenfeld Y
    Arthritis Rheum; 1995 Oct; 38(10):1375-81. PubMed ID: 7575687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wegener's granulomatosis and antineutrophil cytoplasmic autoantibodies.
    Batsakis JG; el-Naggar AK
    Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):906-8. PubMed ID: 8239356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies.
    Bosch X; Guilabert A; Font J
    Lancet; 2006 Jul; 368(9533):404-18. PubMed ID: 16876669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of ANCA positivity.
    Edgar JD
    Ann Rheum Dis; 1996 Aug; 55(8):494-6. PubMed ID: 8774174
    [No Abstract]   [Full Text] [Related]  

  • 12. Wegener's granulomatosis & ANCA-associated diseases: the story continues. Introduction.
    Kekow J; Gross WL
    Adv Exp Med Biol; 1993; 336():v-ix. PubMed ID: 8296593
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
    Gross WL; Schmitt WH; Csernok E
    Clin Exp Immunol; 1993 Jan; 91(1):1-12. PubMed ID: 8419069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANCA-associated vasculitides. Immunological and clinical aspects. Proceedings of the 4th International Workshop on ANCA and the 2nd International Colloquium on Wegener's Granulomatosis and Vasculitic Disorders. May 28-30, 1992, Lübeck, Germany.
    Adv Exp Med Biol; 1993; 336():1-549. PubMed ID: 8296595
    [No Abstract]   [Full Text] [Related]  

  • 16. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis.
    Mareen P; Van De Walle S; Bernaert P; Vanhouteghem H; Dierick J
    Acta Clin Belg; 2003; 58(3):193-200. PubMed ID: 12945480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA related antigens.
    Dolman KM; Goldschmeding R; Sonnenberg A; von dem Borne AE
    APMIS Suppl; 1990; 19():28. PubMed ID: 2285533
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms.
    Davenport A; Lock RJ; Wallington TB
    Thorax; 1994 Mar; 49(3):213-7. PubMed ID: 8202876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
    Wiik A
    Clin Exp Rheumatol; 1993; 11(2):191-201. PubMed ID: 8508563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.